Invivyd

IVVD · NASDAQ

$0.6366+$0.0266 (+4.36%)TodayMarket closed · Oct 20, 7:46 PM ET

Prev close $0.61

Latest news

Press releaseOct 14, 7:01 AM ETGlobe Newswire
Invivyd and the SPEAR Study Group Announce Initiation of “FLINTLOCK” Phase 2 Study of VYD2311, a Monoclonal Antibody for the Potential Treatment of Long COVID or Post-Vaccination Syndrome
NewsSep 29, 2:44 PM ETVandana Singh
Invivyd Outlines Accelerated Approval Submission Path with FDA for COVID-19 Antibody
Press releaseSep 29, 7:01 AM ETGlobe Newswire
Invivyd Announces Positive Topline Results from LIBERTY Phase 3 Study Demonstrating VYD2311 Safety and Tolerability Superior to mRNA-based COVID-19 Vaccine; Announces Regulatory Submission Plans for VYD2311
Press releaseSep 1, 7:01 AM ETGlobe Newswire
Invivyd Appoints Chairman Marc W. Elia as Chief Executive Officer; Approaches Results of VYD2311 studies DECLARATION and LIBERTY
Press releaseAug 13, 4:05 PM ETGlobe Newswire
Invivyd Reports Second Quarter 2026 Financial Results and Recent Business Highlights
Press releaseJul 6, 7:01 AM ETGlobe Newswire
Invivyd Announces Receipt of Twelve Months’ Advanced Notice of Emergency Use Authorization (EUA) Termination for PEMGARDA® and Provides an Update on Next Steps with the U.S. FDA
Press releaseJun 29, 7:00 AM ETGlobe Newswire
NovaBridge Biosciences Appoints Dr. Srishti Gupta as Chief Executive Officer
Press releaseJun 16, 7:01 AM ETGlobe Newswire
Invivyd Announces Completion of Enrollment in Phase 3 LIBERTY Trial Evaluating VYD2311 Antibody Versus mRNA COVID-19 Vaccine
Press releaseJun 9, 7:01 AM ETGlobe Newswire
Invivyd Announces First Participants Dosed in LIBERTY, a Phase 3 Clinical Trial to Evaluate the Safety and Tolerability of VYD2311 Antibody Versus mRNA COVID Vaccine and to Characterize the Safety and Immunology of Antibody and mRNA Vaccine Co-Administration
Press releaseJun 1, 7:01 AM ETGlobe Newswire
Invivyd Announces Completion of Enrollment in Upsized DECLARATION Clinical Trial, a Phase 3 Pivotal Study of VYD2311, an Investigational Antibody to Prevent COVID
NewsMay 14, 1:06 PM ET
12 Health Care Stocks Moving In Thursday's Intraday Session
NewsMay 14, 9:35 AM ET
Invivyd Reports Q1 2026 Results: Full Earnings Call Transcript
NewsMay 14, 7:11 AM ET
Earnings Scheduled For May 14, 2026
Press releaseApr 20, 7:01 AM ETGlobe Newswire
Invivyd Announces Chairman Marc Elia to Speak at POLITICO Health Care Summit
NewsApr 9, 10:54 AM ETAvi Kapoor
BlackBerry Posts Upbeat Q4 Results, Joins Constellation Brands, Marvell Technology And Other Big Stocks Moving Higher On Thursday
NewsMar 30, 5:05 PM ET
12 Health Care Stocks Moving In Monday's After-Market Session
NewsMar 6, 4:05 PM ET
12 Health Care Stocks Moving In Friday's After-Market Session
NewsMar 5, 7:10 AM ET
Invivyd Q4 Earnings Assessment
NewsMar 5, 7:06 AM ET
Invivyd Q4 EPS $0.02 Beats $(0.08) Estimate, Sales $17.207M Beat $15.525M Estimate
NewsMar 5, 6:11 AM ET
Earnings Scheduled For March 5, 2026
NewsDec 22, 4:05 PM ET
12 Health Care Stocks Moving In Monday's After-Market Session
NewsNov 25, 12:21 PM ETAvi Kapoor
This Coinbase Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday
NewsNov 18, 12:53 PM ETAvi Kapoor
Nasdaq Down 1%; Medtronic Earnings Top Views
NewsNov 18, 8:23 AM ETAvi Kapoor
Helmerich and Payne, Invivyd, Home Depot And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
NewsNov 18, 7:06 AM ET
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
NewsNov 18, 6:10 AM ETAvi Kapoor
Why Gorilla Technology Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket
NewsNov 17, 11:39 AM ETAvi Kapoor
Jazz Pharmaceuticals, Sigma Lithium, Zymeworks And Other Big Stocks Moving Higher On Monday
NewsNov 14, 12:06 PM ET
12 Health Care Stocks Moving In Friday's Intraday Session
NewsNov 6, 7:05 AM ET
12 Health Care Stocks Moving In Thursday's Pre-Market Session
NewsNov 6, 6:12 AM ET
Earnings Scheduled For November 6, 2025
NewsNov 5, 2:02 PM ET
Examining the Future: Invivyd's Earnings Outlook
NewsOct 6, 8:53 AM ETAvi Kapoor
This Commerce Bancshares Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
NewsOct 6, 8:02 AM ET
5 Analysts Have This To Say About Invivyd
NewsAug 27, 5:06 PM ET
12 Health Care Stocks Moving In Wednesday's After-Market Session
NewsAug 27, 1:06 PM ET
12 Health Care Stocks Moving In Wednesday's Intraday Session
NewsAug 26, 9:55 AM ETAvi Kapoor
US Stocks Mixed; American Woodmark Posts Downbeat Sales
NewsAug 20, 5:06 PM ET
12 Health Care Stocks Moving In Wednesday's After-Market Session
NewsAug 19, 8:03 AM ET
Demystifying Invivyd: Insights From 5 Analyst Reviews
NewsAug 14, 5:06 PM ET
12 Health Care Stocks Moving In Thursday's After-Market Session
NewsMay 12, 1:07 PM ET
12 Health Care Stocks Moving In Monday's Intraday Session
NewsApr 21, 7:42 AM ET
Market-Moving News for April 21st
NewsFeb 24, 9:20 AM ETVandana Singh
FDA Rejects Invivyd's Request To Expand Emergency Authorization For Preventive COVID-19 Antibody For Immunocompromised Patients
NewsFeb 6, 4:05 PM ET
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Press releaseFeb 5, 9:30 AM ETGlobe Newswire
Invivyd Announces Partnership with Pro Football Coach Jim Harbaugh to Elevate Awareness and Ongoing Impact of COVID-19: Common, Not A Cold
NewsFeb 4, 5:12 AM ETAvi Kapoor
Why Palantir Shares Are Trading Higher By Over 16%; Here Are 20 Stocks Moving Premarket
NewsFeb 3, 10:42 AM ETVandana Singh
Invivyd Touts Encouraging Data From COVID-19 Antibody Trial, Stock Jumps

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.

Latest news

Invivyd and the SPEAR Study Group Announce Initiation of “FLINTLOCK” Phase 2 Study of VYD2311, a Monoclonal Antibody for the Potential Treatment of Long COVID or Post-Vaccination Syndrome

Invivyd Outlines Accelerated Approval Submission Path with FDA for COVID-19 Antibody

Invivyd Announces Positive Topline Results from LIBERTY Phase 3 Study Demonstrating VYD2311 Safety and Tolerability Superior to mRNA-based COVID-19 Vaccine; Announces Regulatory Submission Plans for VYD2311

Invivyd Appoints Chairman Marc W. Elia as Chief Executive Officer; Approaches Results of VYD2311 studies DECLARATION and LIBERTY

Invivyd Reports Second Quarter 2026 Financial Results and Recent Business Highlights

Invivyd Announces Receipt of Twelve Months’ Advanced Notice of Emergency Use Authorization (EUA) Termination for PEMGARDA® and Provides an Update on Next Steps with the U.S. FDA

NovaBridge Biosciences Appoints Dr. Srishti Gupta as Chief Executive Officer

Invivyd Announces Completion of Enrollment in Phase 3 LIBERTY Trial Evaluating VYD2311 Antibody Versus mRNA COVID-19 Vaccine

Invivyd Announces First Participants Dosed in LIBERTY, a Phase 3 Clinical Trial to Evaluate the Safety and Tolerability of VYD2311 Antibody Versus mRNA COVID Vaccine and to Characterize the Safety and Immunology of Antibody and mRNA Vaccine Co-Administration

Invivyd Announces Completion of Enrollment in Upsized DECLARATION Clinical Trial, a Phase 3 Pivotal Study of VYD2311, an Investigational Antibody to Prevent COVID

12 Health Care Stocks Moving In Thursday's Intraday Session

Invivyd Reports Q1 2026 Results: Full Earnings Call Transcript

Earnings Scheduled For May 14, 2026

Invivyd Announces Chairman Marc Elia to Speak at POLITICO Health Care Summit

BlackBerry Posts Upbeat Q4 Results, Joins Constellation Brands, Marvell Technology And Other Big Stocks Moving Higher On Thursday

12 Health Care Stocks Moving In Monday's After-Market Session

12 Health Care Stocks Moving In Friday's After-Market Session

Invivyd Q4 Earnings Assessment

Invivyd Q4 EPS $0.02 Beats $(0.08) Estimate, Sales $17.207M Beat $15.525M Estimate

Earnings Scheduled For March 5, 2026

12 Health Care Stocks Moving In Monday's After-Market Session

This Coinbase Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday

Nasdaq Down 1%; Medtronic Earnings Top Views

Helmerich and Payne, Invivyd, Home Depot And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

Why Gorilla Technology Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket

Jazz Pharmaceuticals, Sigma Lithium, Zymeworks And Other Big Stocks Moving Higher On Monday

12 Health Care Stocks Moving In Friday's Intraday Session

12 Health Care Stocks Moving In Thursday's Pre-Market Session

Earnings Scheduled For November 6, 2025

Examining the Future: Invivyd's Earnings Outlook

This Commerce Bancshares Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday

5 Analysts Have This To Say About Invivyd

12 Health Care Stocks Moving In Wednesday's After-Market Session

12 Health Care Stocks Moving In Wednesday's Intraday Session

US Stocks Mixed; American Woodmark Posts Downbeat Sales

12 Health Care Stocks Moving In Wednesday's After-Market Session

Demystifying Invivyd: Insights From 5 Analyst Reviews

12 Health Care Stocks Moving In Thursday's After-Market Session

12 Health Care Stocks Moving In Monday's Intraday Session

Market-Moving News for April 21st

FDA Rejects Invivyd's Request To Expand Emergency Authorization For Preventive COVID-19 Antibody For Immunocompromised Patients

12 Health Care Stocks Moving In Thursday's Pre-Market Session

Invivyd Announces Partnership with Pro Football Coach Jim Harbaugh to Elevate Awareness and Ongoing Impact of COVID-19: Common, Not A Cold

Why Palantir Shares Are Trading Higher By Over 16%; Here Are 20 Stocks Moving Premarket

Invivyd Touts Encouraging Data From COVID-19 Antibody Trial, Stock Jumps